HomeBUSINESS
BUSINESS

Takeda, Roivant Form Joint Venture for Women’s Health, Prostate Cancer; Takeda Transfers 2 Investigational Products
(Jun.8.2016)

Takeda Pharmaceutical and Roivant Sciences Ltd. announced the formation of Myovant Sciences, a joint venture that will focus on the development of women’s health and prostate cancer solutions. Development and marketing rights to two products Takeda has been developing, relugolix ...
(LOG IN FOR FULL STORY)

News Calendar